Patent details

EP2714018 Title: TRANSDERMAL THERAPEUTIC SYSTEM FOR ADMINISTERING BUPRENORPHIN COMPRISING A ALPHA-HYDROXY-ACID

Basic Information

Publication number:
EP2714018
PCT Application Number:
EP2012058950
Type:
European Patent Granted for LU
Legal Status:
Lapsed
Application number:
EP127231447
PCT Publication Number:
WO2012163665
First applicant's nationality:
Translation Language:
EPO Publication Language:
German
English Title of Invention:
TRANSDERMAL THERAPEUTIC SYSTEM FOR ADMINISTERING BUPRENORPHIN COMPRISING A ALPHA-HYDROXY-ACID
French Title of Invention:
SYSTEME TRANSDERMIQUE COMPRENANT DE LA BUPRENORPHINE AINSI QU'UN ALPHA HYDROXY ACIDE
German Title of Invention:
TRANSDERMALES THERAPEUTISCHES SYSTEM ENTHALTEND BUPRENORPHIN UND EINE ALPHA-HYDROXYSÄURE
SPC Number:

Dates

Filing date:
14/05/2012
Grant date:
28/08/2019
EP Publication Date:
09/04/2014
PCT Publication Date:
06/12/2012
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
28/08/2019
EP B1 Publication Date:
28/08/2019
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
14/05/2020
Expiration date:
14/05/2032
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
21/08/2019
 
 

Name:
Luye Pharma AG
Address:
Am Windfeld 35, 83714 Miesbach, Germany (DE)

Inventor

1

Name:
FAHRMEIR, Julia
Address:
Germany (DE)

2

Name:
SCHURAD, Björn
Address:
Germany (DE)

Priority

Priority Number:
102011076653
Priority Date:
27/05/2011
Priority Country:
Germany (DE)

Classification

IPC classification:
A61K 9/70; A61K 31/485; A61K 47/12; A61P 25/04; A61P 25/36;

Publication

European Patent Bulletin

Issue number:
201935
Publication date:
28/08/2019
Description:
Grant (B1)

Annual Fees

Annual Fee Due Date:
Annual Fee Number:
Expected Payer:
Last Annual Fee Payment Date:
Last Annual Fee Paid Number:
Payer:
Filing date Document type Number of pages